Gene Symbol | SLC22A2 |
---|---|
Entrez Gene | 6582 |
Alt Symbol | OCT2 |
Species | Human |
Gene Type | protein-coding |
Description | solute carrier family 22 (organic cation transporter), member 2 |
Other Description | organic cation transporter 2|solute carrier family 22 member 2 |
Swissprots | Q6PIQ8 Q9NQB9 Q5T7Q6 O15244 Q8NG62 |
Accessions | CAB96133 EAW47601 EAW47602 O15244 AB075951 BAC02720 AK290787 BAF83476 BC030978 AAH30978 BC039899 AAH39899 X98333 CAA66978 NM_003058 NP_003049 NM_153191 |
Function | Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamin, creatinine, amantadine, memantine, acriflavine, 4-[4-(dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as DX-619 and LVFX. This transporter is a major determinant of the anticancer activity of oxaliplatin and may contribute to antitumor specificity. {ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15496291, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16314463, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:16914559, ECO:0000269|PubMed:16951202, ECO:0000269 |
Subcellular Location | Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. |
Tissue Specificity | Mainly expressed in kidney. Localized at the luminal membrane and basolateral membrane of kidney distal tubule and proximal tubules. To a lower extent, expressed in neurons of the cerebral cortex and in various subcortical nuclei (at protein levels). Also detected in secretory phase endometrium; in scattered cells in the stroma. {ECO:0000269|PubMed:11912245, ECO:0000269|PubMed:17393420, ECO:0000269|PubMed:9260930, ECO:0000269|PubMed:9687576}. |
Top Pathways | Choline metabolism in cancer |
OCT2 CRISPR/Cas9 KO Plasmid (h) - sc-402053 from Santa Cruz Biotechnology
|
||||||||
OCT2 HDR Plasmid (h) - sc-402053-HDR from Santa Cruz Biotechnology
|
||||||||
OCT2 Double Nickase Plasmid (h) - sc-402053-NIC from Santa Cruz Biotechnology
|
||||||||
OCT2 Double Nickase Plasmid (h2) - sc-402053-NIC-2 from Santa Cruz Biotechnology
|
||||||||
OCT2 CRISPR Activation Plasmid (h) - sc-402053-ACT from Santa Cruz Biotechnology
|
||||||||
OCT2 CRISPR Activation Plasmid (h2) - sc-402053-ACT-2 from Santa Cruz Biotechnology
|
||||||||
OCT2 Lentiviral Activation Particles (h) - sc-402053-LAC from Santa Cruz Biotechnology
|
||||||||
OCT2 Lentiviral Activation Particles (h2) - sc-402053-LAC-2 from Santa Cruz Biotechnology
|
||||||||
OCT2 siRNA (h) - sc-42554 from Santa Cruz Biotechnology
|
||||||||
OCT2 shRNA Plasmid (h) - sc-42554-SH from Santa Cruz Biotechnology
|
||||||||
OCT2 shRNA (h) Lentiviral Particles - sc-42554-V from Santa Cruz Biotechnology
|
||||||||
SLC22A2/OCT2 RNAi - H00006582-R01 from Novus Biologicals
|
||||||||
MISSION® esiRNA - EHU017241 from Sigma-Aldrich
|
||||||||
SLC22A2 siRNA (Human) - CRH4470 from Cohesion Biosciences
|
||||||||
SLC22A2/OCT2 RNAi - H00006582-R02 from Novus Biologicals
|
||||||||
SLC22A2 - MBS8236850 from MyBioSource
|
||||||||
shRNA set against Human SLC22A2 (NM_003058.3) - SHH409116 from Creative biogene
|
||||||||
Human SLC22A2 siRNA - orb264972 from Biorbyt
|
||||||||
SLC22A2 shRNA Plasmid (Human) - CHH4470 from Cohesion Biosciences
|
||||||||
SLC22A2 miRNA 3'UTR clone - MiUTR4H-TG08180 from Creative biogene
|